1. Abele R, Bernheim J, Cumps E, Buyse M, Kenis Y (1981) Re-evaluation of the combination of CCNU, vincristine, and bleomycin in the treatment of malignant disseminated melanoma. Canc Treat Rep 65:505–506
2. Achterrath W, Raettig R, Franks CR, Seeber S (1984) Aktuelle Cisplatin-Derivate. In: Seeber S, Osieka R, Sack H, Schönenberger H (Hrsg) Das Resistenzproblem bei der Chemo- und Radiotherapie maligner Tumoren, Grundlagen und Klinik. Beitr Onkol 18:58–82, Karger, Basel
3. Adler S, Lowenbraun S, Birch B, Jarrell R, Garrard J (1983) Anguidine (NSC 141 537) by continuous infusion for treatment of solid cancers: Completed phase II study of the southeastern cancer study group. Proc ASCO 2:230, C-898
4. Ahmann DL, Hahn RG, Bisel HF (1972) A comparative study of 1 (2-chloroethyl)-cyclohexyl-l-nitrosurea (NSC-79037) and imidazole carboxamide (NSC-45388) with vincristine (NSC-67 574) in the palliation of disseminated malignant melanoma. Cancer Res 32:2432–2434
5. Ahmann DL, Hahn RG, Bisel HF (1974) Evaluation of l-(2-chloroethyl-3–4-methyl-cyclohexyl)-l-nitrosurea (methyl-CCNU, NSC-95441) versus combined imidazole carboxamide (NSC-45388) and vincristine (NSC-67 574) in palliation of disseminated malignant melanoma. Cancer 33:615–618